Equate Fibre Gummies
Natural health product licensed in Canada
- Other names
- Dr Nutrition Fibre Gummies, Exact Fibre Gummies, Fruity Bites, Life Fibre Gummies, MapleLife Nutrition Fibre Gummies, Nutralab Canada Fibre Gummies
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80060804
- Status
- Active licence
- Licence date
- 12 May 2015
- Revision date
- Not provided
- Form
- Bloc
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fructooligosaccharides Source : Fructooligosaccharides | 1.5 Grammes | Not calculated |
Non-medicinal ingredients
Cire de Carnauba, Jus de genipap concentré, Jus de carotte noire, Sucrose, Saveur de cerise, Citrate de sodium, Saveur de poire, Saveur de framboise bleue, Pectine, Huile végétale, Acide citrique, Jus de pastèque concentré
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years ; maximum: 13 years | 1 Bloc(s) | 2 Tous les jours |
| Adultes et adolescents | minimum: 14 years | 2 Bloc(s) | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Source of fiber for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity has been known to occur. Products providing greater or equal to 5 g per day May cause mild gastro-intestinal discomfort (such as gas, bloating, cramps).
- Précautions et mises en garde
If symptoms worsen or if laxative effect does not occur within seven days, consult a health care practitioner. If you are taking medications which inhibit peristaltic movement, consult a health care practitioner prior to use (e.g. opioids, loperamide). If you have symptoms such as abdominal pain, nausea, vomiting or fever, consult a health care practitioner prior to use. If you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if your child has diabetes.
Source
Official Health Canada record, licence 80060804
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.